BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 30606137)

  • 1. A phase II randomized controlled trial of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy.
    Alibhai SMH; Santa Mina D; Ritvo P; Tomlinson G; Sabiston C; Krahn M; Durbano S; Matthew A; Warde P; O'Neill M; Timilshina N; Segal R; Culos-Reed N
    BMC Cancer; 2019 Jan; 19(1):2. PubMed ID: 30606137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II RCT and economic analysis of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy.
    Alibhai SM; Santa Mina D; Ritvo P; Sabiston C; Krahn M; Tomlinson G; Matthew A; Segal R; Warde P; Durbano S; O'Neill M; Culos-Reed N
    BMC Cancer; 2015 Apr; 15():312. PubMed ID: 25908311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol for a phase III RCT and economic analysis of two exercise delivery methods in men with PC on ADT.
    Alibhai SMH; Ritvo P; Santa Mina D; Sabiston C; Krahn M; Tomlinson G; Matthew A; Lukka H; Warde P; Durbano S; O'Neill M; Culos-Reed SN
    BMC Cancer; 2018 Oct; 18(1):1031. PubMed ID: 30352568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Home-based versus supervised group exercise in men with prostate cancer on androgen deprivation therapy: A randomized controlled trial and economic analysis.
    Alibhai SMH; Papadopoulos E; Mina DS; Ritvo P; Tomlinson G; Sabiston CM; Durbano S; Bremner KE; Chiarotto J; Matthew A; Warde P; O'Neill M; Culos-Reed SN
    J Geriatr Oncol; 2024 Jan; 15(1):101646. PubMed ID: 37976654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial.
    Cormie P; Galvão DA; Spry N; Joseph D; Chee R; Taaffe DR; Chambers SK; Newton RU
    BJU Int; 2015 Feb; 115(2):256-66. PubMed ID: 24467669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Group-based exercise in daily clinical practice to improve physical fitness in men with prostate cancer undergoing androgen deprivation therapy: study protocol.
    Østergren P; Ragle AM; Jakobsen H; Klausen TW; Vinther A; Sønksen J
    BMJ Open; 2016 Jun; 6(6):e011460. PubMed ID: 27357198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: a pilot randomized controlled trial.
    Dawson JK; Dorff TB; Todd Schroeder E; Lane CJ; Gross ME; Dieli-Conwright CM
    BMC Cancer; 2018 Apr; 18(1):368. PubMed ID: 29614993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preference-based versus randomized controlled trial in prostate cancer survivors: Comparison of recruitment, adherence, attrition, and clinical outcomes.
    Alibhai SMH; Papadopoulos E; Durbano S; Tomlinson G; Mina DS; Ritvo P; Sabiston CM; Matthew AG; Chiarotto J; Sidani S; Culos-Reed SN
    Front Oncol; 2022; 12():1033229. PubMed ID: 36578945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of aerobic- and resistance-emphasised exercise on cardiometabolic health and quality of life in men receiving androgen deprivation therapy for prostate cancer: Protocol for a feasibility trial.
    Murphy K; Kehoe B; Denieffe S; Hacking D; Fairman CM; Harrison M
    Contemp Clin Trials; 2024 Jan; 136():107388. PubMed ID: 37972755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial on the effectiveness of strength training on clinical and muscle cellular outcomes in patients with prostate cancer during androgen deprivation therapy: rationale and design.
    Thorsen L; Nilsen TS; Raastad T; Courneya KS; Skovlund E; Fosså SD
    BMC Cancer; 2012 Mar; 12():123. PubMed ID: 22458865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of recreational soccer in men with prostate cancer undergoing androgen deprivation therapy: study protocol for the 'FC Prostate' randomized controlled trial.
    Uth J; Schmidt JF; Christensen JF; Hornstrup T; Andersen LJ; Hansen PR; Christensen KB; Andersen LL; Helge EW; Brasso K; Rørth M; Krustrup P; Midtgaard J
    BMC Cancer; 2013 Dec; 13():595. PubMed ID: 24330570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of recreational football on bone health, body composition, and physical functioning in men with prostate cancer undergoing androgen deprivation therapy: 32-week follow-up of the FC prostate randomised controlled trial.
    Uth J; Hornstrup T; Christensen JF; Christensen KB; Jørgensen NR; Schmidt JF; Brasso K; Jakobsen MD; Sundstrup E; Andersen LL; Rørth M; Midtgaard J; Krustrup P; Helge EW
    Osteoporos Int; 2016 Apr; 27(4):1507-1518. PubMed ID: 26572756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy.
    Lee CE; Leslie WD; Lau YK
    BMC Cancer; 2012 Mar; 12():103. PubMed ID: 22436542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erratum.
    Mult Scler; 2016 Oct; 22(12):NP9-NP11. PubMed ID: 26041800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR.
    Galvão DA; Spry N; Denham J; Taaffe DR; Cormie P; Joseph D; Lamb DS; Chambers SK; Newton RU
    Eur Urol; 2014 May; 65(5):856-64. PubMed ID: 24113319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial comparing changes in fitness with or without supervised exercise in patients initiated on enzalutamide and androgen deprivation therapy for non-metastatic castration-sensitive prostate cancer (EXTEND).
    Harrison MR; Davis PG; Khouri MG; Bartlett DB; Gupta RT; Armstrong AJ; McNamara MA; Zhang T; Anand M; Onyenwoke K; Edwardson S; Craig D; Michalski M; Wu Y; Oyekunle T; Coyne B; Coburn A; Jones LW; George DJ
    Prostate Cancer Prostatic Dis; 2022 Mar; 25(1):58-64. PubMed ID: 35273377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of exercise on treatment-related adverse effects for patients with prostate cancer receiving androgen-deprivation therapy: a systematic review.
    Gardner JR; Livingston PM; Fraser SF
    J Clin Oncol; 2014 Feb; 32(4):335-46. PubMed ID: 24344218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol for GET FIT Prostate: a randomized, controlled trial of group exercise training for fall prevention and functional improvements during and after treatment for prostate cancer.
    Winters-Stone KM; Li F; Horak F; Dieckmann N; Hung A; Amling C; Beer TM
    Trials; 2021 Nov; 22(1):775. PubMed ID: 34742325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving bone health in men with prostate cancer receiving androgen deprivation therapy: Results of a randomized phase 2 trial.
    Alibhai SMH; Breunis H; Timilshina N; Hamidi MS; Cheung AM; Tomlinson GA; Manokumar T; Samadi O; Sandoval J; Durbano S; Warde P; Jones JM
    Cancer; 2018 Mar; 124(6):1132-1140. PubMed ID: 29211305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer.
    Taaffe DR; Buffart LM; Newton RU; Spry N; Denham J; Joseph D; Lamb D; Chambers SK; Galvão DA
    BJU Int; 2018 Feb; 121(2):194-202. PubMed ID: 28872752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.